Caterina Vicidomini1, Mariarosaria Panico1, Adelaide Greco2, Sara Gargiulo1, Anna Rita Daniela Coda1, Antonella Zannetti1, Matteo Gramanzini1, Giovanni N Roviello3, Mario Quarantelli3, Bruno Alfano3, Bertrand Tavitian4, Frederic Dollé5, Marco Salvatore6, Arturo Brunetti2, Sabina Pappatà7. 1. Institute of Biostructure and Bioimaging, CNR, Naples, Italy; CEINGE, Biotecnologie Avanzate, s.c.a.r.l., Naples, Italy. 2. Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy; CEINGE, Biotecnologie Avanzate, s.c.a.r.l., Naples, Italy. 3. Institute of Biostructure and Bioimaging, CNR, Naples, Italy. 4. Inserm U970, PARCC, Université Paris Descartes, Hôpital Européen Georges Pompidou, Paris, France; CEA, I2BM, Service Hospitalier Frédéric Joliot, Orsay, France. 5. CEA, I2BM, Service Hospitalier Frédéric Joliot, Orsay, France. 6. Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy. 7. Institute of Biostructure and Bioimaging, CNR, Naples, Italy. Electronic address: sabina.pappata@ibb.cnr.it.
Abstract
INTRODUCTION: The translocator protein 18 kDa (TSPO), a biochemical marker of neuroinflammation, is highly expressed in the brain activated microglia and it is also expressed by peripheral inflammatory cells and normal peripheral tissues. Thus, development of radioligands for the TSPO may contribute to further understanding the in vivo TSPO function in central and peripheral inflammatory processes and other pathologies. Here, we report the biodistribution, the specific binding and the radiometabolites of [(18)F]DPA-714, a promising fluorinated PET radiotracer, in normal mice using a microPET/CT scanner. METHODS: The in vivo biodistribution and kinetics of [(18)F]DPA-714 were measured in mice brain and peripheral tissues. Specific binding to TSPO sites was assessed using pharmacological competitive studies by means of saturation experiments performed by i.v. injection of 1mg/kg of unlabeled DPA-714 or 3mg/kg of unlabeled PK11195. A region of interest analysis was performed to generate time-activity curves in the brain, heart, lung, kidney, spleen and liver. Metabolites assay was performed in the plasma and peripheral organs by radio-HPLC. RESULTS: [(18)F]DPA-714 reached high concentration in lung, heart, kidney and spleen, tissues well known to be rich in TSPO sites. [(18)F]DPA-714 kinetics were faster in the lung and slower in the kidney. Pre-injection of unlabeled DPA-714 or PK11195 inhibited about 80% of [(18)F]DPA-714 uptake in the lung and heart (p<0.0005). The percentage of inhibition in the kidney was lower and achieved at later times only with DPA-714 (p<0.05) but not with PK11195. Sixty minutes after radiotracer injection only unmetabolized radioligand was found in the brain, lung, heart and spleen. CONCLUSION: These results suggest that [(18)F]DPA-714 is a suitable PET ligand for imaging in mice brain and peripheral tissues since it binds with high specificity TSPO binding sites and it is almost unchanged at 60 minutes after radiotracer injection in the brain and TSPO-rich regions.
INTRODUCTION: The translocator protein 18 kDa (TSPO), a biochemical marker of neuroinflammation, is highly expressed in the brain activated microglia and it is also expressed by peripheral inflammatory cells and normal peripheral tissues. Thus, development of radioligands for the TSPO may contribute to further understanding the in vivo TSPO function in central and peripheral inflammatory processes and other pathologies. Here, we report the biodistribution, the specific binding and the radiometabolites of [(18)F]DPA-714, a promising fluorinated PET radiotracer, in normal mice using a microPET/CT scanner. METHODS: The in vivo biodistribution and kinetics of [(18)F]DPA-714 were measured in mice brain and peripheral tissues. Specific binding to TSPO sites was assessed using pharmacological competitive studies by means of saturation experiments performed by i.v. injection of 1mg/kg of unlabeled DPA-714 or 3mg/kg of unlabeled PK11195. A region of interest analysis was performed to generate time-activity curves in the brain, heart, lung, kidney, spleen and liver. Metabolites assay was performed in the plasma and peripheral organs by radio-HPLC. RESULTS: [(18)F]DPA-714 reached high concentration in lung, heart, kidney and spleen, tissues well known to be rich in TSPO sites. [(18)F]DPA-714 kinetics were faster in the lung and slower in the kidney. Pre-injection of unlabeled DPA-714 or PK11195 inhibited about 80% of [(18)F]DPA-714 uptake in the lung and heart (p<0.0005). The percentage of inhibition in the kidney was lower and achieved at later times only with DPA-714 (p<0.05) but not with PK11195. Sixty minutes after radiotracer injection only unmetabolized radioligand was found in the brain, lung, heart and spleen. CONCLUSION: These results suggest that [(18)F]DPA-714 is a suitable PET ligand for imaging in mice brain and peripheral tissues since it binds with high specificity TSPO binding sites and it is almost unchanged at 60 minutes after radiotracer injection in the brain and TSPO-rich regions.
Authors: Jatta S Takkinen; Francisco R López-Picón; Rana Al Majidi; Olli Eskola; Anna Krzyczmonik; Thomas Keller; Eliisa Löyttyniemi; Olof Solin; Juha O Rinne; Merja Haaparanta-Solin Journal: J Cereb Blood Flow Metab Date: 2016-01-01 Impact factor: 6.200
Authors: S Gargiulo; S Anzilotti; A R D Coda; M Gramanzini; A Greco; M Panico; A Vinciguerra; A Zannetti; C Vicidomini; F Dollé; G Pignataro; M Quarantelli; L Annunziato; A Brunetti; M Salvatore; S Pappatà Journal: Eur J Nucl Med Mol Imaging Date: 2016-01-27 Impact factor: 9.236
Authors: Dianne E Lee; Xuyi Yue; Wael G Ibrahim; Margaret R Lentz; Kristin L Peterson; Elaine M Jagoda; Michael Kassiou; Dragan Maric; William C Reid; Dima A Hammoud Journal: J Neuroinflammation Date: 2015-09-17 Impact factor: 8.322
Authors: Danielle A Simmons; Michelle L James; Nadia P Belichenko; Sarah Semaan; Christina Condon; Jason Kuan; Adam J Shuhendler; Zheng Miao; Frederick T Chin; Frank M Longo Journal: Hum Mol Genet Date: 2018-08-15 Impact factor: 6.150
Authors: Bin Liu; Kevin X Le; Mi-Ae Park; Shuyan Wang; Anthony P Belanger; Shipra Dubey; Jeffrey L Frost; Peter Holton; Vladimir Reiser; Paul A Jones; William Trigg; Marcelo F Di Carli; Cynthia A Lemere Journal: J Neurosci Date: 2015-11-25 Impact factor: 6.167